Common questions about this stock, answered from live data
As of 25 Sept 2026, 3:30 pm, the share price of Concord Drugs Ltd (CONCORD) is ₹78.33 on BSE.
Concord Drugs Ltd (CONCORD) has touched a 52-week high of ₹92.52 and a 52-week low of ₹61.
The total market capitalization of Concord Drugs Ltd is ₹103.2 Cr.
Concord Drugs Ltd is currently trading at a Price-to-Earnings (P/E) ratio of 50.21.
The Earnings Per Share (EPS) for Concord Drugs Ltd for the trailing twelve months is ₹1.56.
The International Securities Identification Number (ISIN) for Concord Drugs Ltd is INE858L01010.
Concord Drugs Ltd (CONCORD) is listed and traded on the BSE.
You can buy shares by opening a Demat and Trading account with Indiabulls Securities, completing your KYC, and placing a delivery or intraday order through our platform.
We charge a flat brokerage of ₹11 per executed order across all segments. Statutory charges like STT, Exchange Transaction Charges, and GST are applicable as per SEBI guidelines.
The Indian equity markets (NSE and BSE) are open from 9:15 AM to 3:30 PM, Monday to Friday, excluding exchange-declared holidays.
Latest corporate actions including dividends, splits, and bonuses are updated in the 'Corporate Actions' section of the Stock Details page and are also available on the official NSE/BSE websites.
Disclaimer: The FAQs above are generated based on historical and real-time market data provided by exchanges. This information is for educational purposes only and does not constitute financial advice, buy/sell recommendations, or price targets. Investment in the securities market is subject to market risks. Read all related documents carefully before investing.
